{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:34:29Z","timestamp":1786991669582,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2021-ZLLH-05"],"award-info":[{"award-number":["2021-ZLLH-05"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2021-ZLLH-14"],"award-info":[{"award-number":["2021-ZLLH-14"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT20YG126"],"award-info":[{"award-number":["DUT20YG126"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171330"],"award-info":[{"award-number":["32171330"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22078050"],"award-info":[{"award-number":["22078050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020761","name":"Liaoning Cancer Institute and Hospital","doi-asserted-by":"publisher","award":["21-172-9-03"],"award-info":[{"award-number":["21-172-9-03"]}],"id":[{"id":"10.13039\/501100020761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020761","name":"Liaoning Cancer Institute and Hospital","doi-asserted-by":"publisher","award":["2021JH2 \/ 10300061"],"award-info":[{"award-number":["2021JH2 \/ 10300061"]}],"id":[{"id":"10.13039\/501100020761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002980","name":"Dalian University of Technology","doi-asserted-by":"publisher","award":["XLYC1807184"],"award-info":[{"award-number":["XLYC1807184"]}],"id":[{"id":"10.13039\/501100002980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002980","name":"Dalian University of Technology","doi-asserted-by":"publisher","award":["LD202027"],"award-info":[{"award-number":["LD202027"]}],"id":[{"id":"10.13039\/501100002980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017683","name":"Dalian Science and Technology Innovation Fund","doi-asserted-by":"publisher","award":["2020JJ26GX025"],"award-info":[{"award-number":["2020JJ26GX025"]}],"id":[{"id":"10.13039\/501100017683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017683","name":"Dalian Science and Technology Innovation Fund","doi-asserted-by":"publisher","award":["2020JJ26SN050"],"award-info":[{"award-number":["2020JJ26SN050"]}],"id":[{"id":"10.13039\/501100017683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcis.2022.12.018","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T19:42:07Z","timestamp":1670528527000},"page":"388-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["pH-responsive organic\/inorganic hybrid nanocolloids for transcellular delivery of ribonucleolytic payloads toward targeted anti-glioma therapy"],"prefix":"10.1016","volume":"634","author":[{"given":"Hongyan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcis.2022.12.018_b0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/acs.nanolett.1c03293","article-title":"Multistage systemic and cytosolic protein delivery for effective cancer treatment","volume":"22","author":"Fu","year":"2022","journal-title":"Nano Lett."},{"issue":"9","key":"10.1016\/j.jcis.2022.12.018_b0010","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/bjo.2007.116616","article-title":"Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness","volume":"91","author":"Raftery","year":"2007","journal-title":"Brit. J. Ophthalmol."},{"issue":"6_suppl","key":"10.1016\/j.jcis.2022.12.018_b0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1200\/JCO.2021.39.6_suppl.124","article-title":"BXCL701, first-in-class oral activator of systemic innate immunity pathway, combined with pembrolizumab (Keytruda) in men with metastatic castration-resistant prostate cancer (mCRPC)","volume":"39","author":"Aggarwal","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"41","key":"10.1016\/j.jcis.2022.12.018_b0020","doi-asserted-by":"crossref","first-page":"14396","DOI":"10.1021\/jacs.7b06597","article-title":"Cytosolic delivery of proteins by bioreversible esterification","volume":"139","author":"Mix","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jcis.2022.12.018_b0025","doi-asserted-by":"crossref","first-page":"18214","DOI":"10.1021\/acsnano.1c07166","article-title":"Redox-responsive molecularly imprinted nanoparticles for targeted intracellular delivery of protein toward cancer therapy","volume":"15","author":"Lu","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jcis.2022.12.018_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3762\/bjnano.11.10","article-title":"Internalization mechanisms of cell-penetrating peptides","volume":"11","author":"Ruseska","year":"2020","journal-title":"Beilstein J. Nanotech."},{"key":"10.1016\/j.jcis.2022.12.018_b0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.addr.2021.02.003","article-title":"Advances in peptide-mediated cytosolic delivery of proteins","volume":"171","author":"Sanchez-Navarro","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jcis.2022.12.018_b0040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2217\/nnm-2016-0393","article-title":"Intracellular delivery of proteins by nanocarriers","volume":"12","author":"Ray","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jcis.2022.12.018_b0045","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2147\/IJN.S363168","article-title":"A ternary synergistic eNOS gene delivery system based on calcium ion and L-arginine for accelerating angiogenesis by maximizing NO production","volume":"17","author":"Zhang","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.jcis.2022.12.018_b0050","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1021\/acsami.0c21422","article-title":"Spatiotemporal concurrent liberation of cytotoxins from dual-prodrug nanomedicine for synergistic antitumor therapy","volume":"13","author":"Zhang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"30","key":"10.1016\/j.jcis.2022.12.018_b0055","doi-asserted-by":"crossref","first-page":"2006619","DOI":"10.1002\/adma.202006619","article-title":"All-in-one dendrimer-based lipid nanoparticles enable precise HDR-mediated gene editing in vivo","volume":"33","author":"Farbiak","year":"2021","journal-title":"Adv. Mater."},{"issue":"46","key":"10.1016\/j.jcis.2022.12.018_b0060","doi-asserted-by":"crossref","first-page":"2000013","DOI":"10.1002\/adma.202000013","article-title":"A multistage cooperative nanoplatform enables intracellular co-delivery of proteins and chemotherapeutics for cancer therapy","volume":"32","author":"Zhang","year":"2020","journal-title":"Adv. Mater."},{"issue":"18","key":"10.1016\/j.jcis.2022.12.018_b0065","doi-asserted-by":"crossref","first-page":"1807677","DOI":"10.1002\/adfm.201807677","article-title":"Lung-endothelium-targeted nanoparticles based on a pH-sensitive lipid and the GALA peptide enable robust gene silencing and the regression of metastatic lung cancer","volume":"29","author":"Abd Elwakil","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jcis.2022.12.018_b0070","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41467-018-07264-0","article-title":"Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.jcis.2022.12.018_b0075","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.7150\/thno.19279","article-title":"Albumin-gold nanorod nanoplatform for cell-mediated tumoritropic delivery with homogenous chemodrug distribution and enhanced retention ability","volume":"7","author":"Chiu","year":"2017","journal-title":"Theranostics"},{"issue":"31","key":"10.1016\/j.jcis.2022.12.018_b0080","doi-asserted-by":"crossref","first-page":"1801570","DOI":"10.1002\/adma.201801570","article-title":"Unlockable nanocomplexes with self-accelerating nucleic acid release for effective staged gene therapy of cardiovascular diseases","volume":"30","author":"Nie","year":"2018","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.jcis.2022.12.018_b0085","doi-asserted-by":"crossref","first-page":"15824","DOI":"10.1021\/acsnano.1c03301","article-title":"Self-assembling peptide dendron nanoparticles with high stability and a multimodal antimicrobial mechanism of action","volume":"15","author":"Lai","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jcis.2022.12.018_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119358","article-title":"Polymers for cytosolic protein delivery","volume":"218","author":"Lv","year":"2019","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.jcis.2022.12.018_b0095","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1039\/C8SC04160A","article-title":"Superoxide dismutase transcellular shuttle constructed from dendritic MOF and charge reversible protein derivatives","volume":"10","author":"Wang","year":"2019","journal-title":"Chem. Sci."},{"issue":"11","key":"10.1016\/j.jcis.2022.12.018_b0100","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.biomaterials.2010.12.057","article-title":"Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity","volume":"32","author":"Pittella","year":"2011","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.jcis.2022.12.018_b0105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1039\/C6BM00011H","article-title":"Calcium phosphate-based organic-inorganic hybrid nanocarriers with pH-responsive on\/off switch for photodynamic therapy","volume":"4","author":"Nomoto","year":"2016","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jcis.2022.12.018_b0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2019.07.004","article-title":"Enzyme responsive drug delivery systems in cancer treatment","volume":"308","author":"Shahriari","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jcis.2022.12.018_b0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14712590802631862","article-title":"Targeted therapeutic RNases (ImmunoRNases)","volume":"9","author":"Schirrmann","year":"2009","journal-title":"Expert Opin. Biol. Th."},{"issue":"2","key":"10.1016\/j.jcis.2022.12.018_b0120","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/acsnano.9b09024","article-title":"Protein@inorganic nanodumpling system for high-loading protein delivery with activatable fluorescence and magnetic resonance bimodal imaging capabilities","volume":"14","author":"Zhu","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.jcis.2022.12.018_b0125","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/acs.nanolett.7b04976","article-title":"Hierarchical nanoassemblies-assisted combinational delivery of cytotoxic protein and antibiotic for cancer treatment","volume":"18","author":"Liu","year":"2018","journal-title":"Nano Lett."},{"issue":"16","key":"10.1016\/j.jcis.2022.12.018_b0130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/nar\/gky496","article-title":"Argonaute-based programmable RNase as a tool for cleavage of highly-structured RNA","volume":"46","author":"Dayeh","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.jcis.2022.12.018_b0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0141-8130(98)00060-9","article-title":"Circular dichroism study of ribonuclease A mutants containing the minimal structural requirements for dimerization and swapping","volume":"23","author":"Catanzano","year":"1998","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.jcis.2022.12.018_b0140","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/mp3002733","article-title":"RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis","volume":"9","author":"Danhier","year":"2012","journal-title":"Mol. Pharmaceut."}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979722021646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979722021646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:46:58Z","timestamp":1777412818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979722021646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":28,"alternative-id":["S0021979722021646"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2022.12.018","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pH-responsive organic\/inorganic hybrid nanocolloids for transcellular delivery of ribonucleolytic payloads toward targeted anti-glioma therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2022.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}